Back to company

MACURE PHARMA ApS: Financial statements 2024

CVR: 35234748

MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 39,051,226 and a net result of DKK 8,495,013 compared with DKK 8,790,375 the year before. That is an increase of 61.6% compared with the year before. Equity amounted to DKK 14,979,645. The solvency ratio was 7.4%. The company had 13 employees in the financial year.

Gross Profit
39,051,226 kr.
Profit/Loss
8,495,013 kr.
Equity
14,979,645 kr.
Total Assets
202,510,136 kr.
Employees
13

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-39.1 mio.8.5 mio.15 mio.13
2023-24.2 mio.8.8 mio.14.2 mio.13
2022-37.5 mio.17.9 mio.23.4 mio.10
2021-25 mio.5 mio.10.5 mio.6
2020-15.1 mio.5.3 mio.10.5 mio.10

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MACURE PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

MACURE PHARMA ApS: The 2023 annual report is outJun 19, 2024

MACURE PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 24,158,862, and the net result was DKK 8,790,375.

About MACURE PHARMA ApS

MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.